| Harold R Oster, MD | |
|
2855 Campus Dr, Suite 400, Plymouth, MN 55441-2659 | |
| (763) 577-7400 | |
| Not Available |
| Full Name | Harold R Oster |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 2855 Campus Dr, Plymouth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417915695 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 46603 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allina Health Home Health | Saint paul, MN | Home health agency |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
Surgical Information Systems (SIS), a leader in perioperative information systems, announced today that SIS Anesthesia Version 5 has been certified to meet 2011/2012 Stage 1 meaningful use measures as a modular Electronic Health Record.
› Verified 6 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
Surgical Information Systems (SIS), a leader in perioperative information systems, announced today that SIS Anesthesia Version 5 has been certified to meet 2011/2012 Stage 1 meaningful use measures as a modular Electronic Health Record.
› Verified 6 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
Surgical Information Systems (SIS), a leader in perioperative information systems, announced today that SIS Anesthesia Version 5 has been certified to meet 2011/2012 Stage 1 meaningful use measures as a modular Electronic Health Record.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harold R Oster, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-4813 | Harold R Oster, MD 2855 Campus Dr, Suite 400, Plymouth, MN 55441-2659 Ph: (763) 577-7400 |
News Archive
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
Building on an earlier study that used Oncomine to identify ETS-fusion proteins in prostate cancer (Science, Oct 28 2005), Tomlins et al. report the identification of four additional classes of ETS rearrangements in prostate cancer, each of which activates ETV1 by a different genetic mechanism (Nature, Aug 2 2007).
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
Surgical Information Systems (SIS), a leader in perioperative information systems, announced today that SIS Anesthesia Version 5 has been certified to meet 2011/2012 Stage 1 meaningful use measures as a modular Electronic Health Record.
› Verified 6 days ago
Erica N. Roberson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N, #300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 | |
Dr. Thomas John Kaminsky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 | |
Alfred P. Chiang, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Campus Dr, Suite 100, Plymouth, MN 55441 Phone: 763-519-0634 Fax: 763-519-0636 | |
Mr. Bradley Daniel Chmielewski, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 Campus Dr Ste 10, Plymouth, MN 55441 Phone: 763-559-2171 | |
Daniela T Ouzounova, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2855 Campus Dr, Ste. 400, Plymouth, MN 55441 Phone: 763-577-7400 | |
Stephanie Norris, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3007 Harbor Ln N, Plymouth, MN 55447 Phone: 952-993-8900 | |
Dr. Daniel Mark Van Handel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15700 37th Ave N Ste 300, Plymouth, MN 55446 Phone: 612-871-1145 Fax: 612-870-5491 |